Zusammenfassung
Die koronare Herzkrankheit (KHK) ist nach angiographischen Kriterien definiert als das Vorliegen von Lumeneinengungen der Koronarien >50%. Die mit einer solchen Lumenreduktion einhergehenden hämodynamischen Veränderungen stellen heute die Grenze für die Nachweisbarkeit der KHK mit den sensitivsten funktionellen Untersuchungsverfahren der Ischämiediagnostik dar. Bei Verdacht auf das Vorliegen einer KHK oder atypischer Beschwerdesymptomatik wird die Indikationsstellung zur Herzkatheterdiagnostik durch eine Ischämiediagnostik abgesichert. Diese kann entweder durch ergometrische Belastungstests oder durch bildgebende Verfahren in Kombination mit ergometrischer oder pharmakologischer Belastung erfolgen. Etabliert sind die Myokardszintigraphie und die Stressechokardiographie sowie in zunehmenden Maße auch die Stressmagnetresonanztomographie. Neben dem sensitiven Ischämienachweis hat der technische Fortschritt in der Computertomographie (CT) und der Magnetresonanztomographie (MRT) die Möglichkeit einer nichtinvasiven Darstellung der Koronargefäße und der Gefäßwandmorphologie eröffnet. Während die CT-Koronarangiographie mit ihrer hohen räumlichen Auflösung an der Schwelle zur klinischen Anwendung bei selektierten Patienten steht, hat die MRT das Potenzial, von der Wandbewegungsanalyse über die Perfusion und Koronarflussmessung bis hin zur Plaquecharakterisierung zukünftig eine „kardiovaskuläre Rundumuntersuchung“ zu gewährleisten.
Abstract
In cases of stable or to a large extent symptom-free coronary heart disease (CHD) and atypical symptomatology, the indication for diagnostic cardiac catheterization is first confirmed by noninvasive diagnostics of ischemia. This can be carried out either with ergometric stress tests or imaging procedures in combination with ergometric or pharmacological stress. Myocardial scintigraphy and stress echocardiography are established techniques and to an increasing extent stress magnetic resonance imaging (MRI). In addition to sensitivity in providing evidence for ischemia, technical improvements in computed tomography (CT) and MRI have opened up new possibilities for visualizing coronary vessels and vascular wall morphology. While CT coronary angiography with its high spatial resolution is on the threshold of clinical application for selected patients, MRI has the potential for furnishing information on wall movement analysis, perfusion, coronary flow measurement, and plaque characterization to become the future cardiovascular “all-round examination”.
Literatur
Achenbach S, Moselewski F, Ropers D et al. (2004) Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography. Circulation 109: 14–17
Achenbach S (2003) Klinischer Stellenwert der Cardio-CT-Koronarangiographie. Herz 28: 119–125
AlSaadi N, Nagel E, Gross M et al. (2000) Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101: 1379–1383
Baer FM, Erdmann E (2004) Diagnosis of coronary artery disease: from established techniques to recent developments. Medicographia 26: 407–416
Baer FM, Voth E, Theissen P et al. (1994) Comparison of dobutamine-magnetic resonance imaging and dobutamine-99mTc-methoxy-isobutyl-isonitrile SPECT in the diagnosis of coronary artery disease. Radiology 193: 203–209
Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338: 1650–1656
Botnar RM, Buecker A, Wiethoff AJ et al. (2004) In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 110: 1463–1466
De Backer G, Ambrosioni E, Borch-Johnsen K et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24: 1601–1610
Dissmann W, deRidder M (2002) The soft science of German cardiology. Lancet 359: 2027–2029
Erbel R (1996) The dawn of a new era—Non-invasive coronary imaging. Herz 21: 75–77
Fayad ZA, Fuster V, Nikolaou K, Becker C (2002) Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation 106: 2026–2034
Fayad ZA, Fuster V, Fallon JT et al. (2000) Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102: 506–510
Garber AM, Solomon NA (1999) Cost effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 130: 719–728
Gibbons RJ, Abrams J, Chatterjee K et al. (2003) ACC7AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. Circulation 107: 149–158
Gibbons RJ, Balady GJ, Beasly JW et al. (1997) ACC7AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Commmitees on exercise testing). Circulation 96: 345–354
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305
Haberl R, Becker A, Leber E et al. (2002) Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1764 patients. J Am Coll Cardiol 37: 451–457
Husten L (1998) Global epidemic of cardiovascular disease predicted. Lancet 352: 1530
Kim WY, Danias PG, Stuber M et al. (2001) Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 345: 1863–1869
Kondos GT, Hoff JA, Sevrukov A et al. (2003) Electron-beam tomography coronary artery calcium and cardiac events. Circulation 107: 2571–2576
Marwick TH (1996) Cardiac stress testing and imaging. A clinician’s guide. Churchill Livingstone, New York
Masugata H, Lafitte S, Peters B, Monet Strachan G, DeMaria AN (2001) Comparison of real-time and intermittent triggered myocardial contrast echocardiography for quantification of coronary stenosis severity and transmural perfusion gradient. Circulation 104: 1550–1556
Nagel E, Lehmkuhl HB, Bocksch W et al. (1999) Non invasive diagnosis of ischemia induced wall motion abnormalities using high dose dobutamine stress magnetic resonance imaging: Comparison to dobutamine stress echocardiography. Circulation 99: 763–770
Nixdorff U, Wagner S, Erbel R, Weitzel P, Mohr-Kahaly S, Meyer J (1995) Normalwerte für die Dobutamin-Streßechokardiographie: Dtsch Med Wochenschr 120: 1761–1767
Picano E, Lattanz F, Orlandini A, Marini C, l’Abbate A (1991) Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 17: 666–669
Pryor D, Shaw L, McCants C et al. (1993) Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 118: 81–90
Ropers D, Baum U, Pohle K et al. (2003) Detection of coronary artery stenosis with thin-slice multi-detector row spiral computed tomography and multiplanar reconstruction. Circulation 107: 664–666
Schmermund A, Möhlenkamp S, Stang A et al. for the Heinz Nixdorf Recall Study Investigative Group (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf Recall study. Am Heart J 144: 212–218
Stary HC (2000) Natural history of calcium deposits in atherosclerosis progression and regression. Z Kardiol 89: II/28–II/35
Weber OM, Pujadas S, Martin AJ, Higgins CB (2004) Free-breathing, three-dimensional coronary artery magnetic resonance angiography: comparison of sequences. J Magn Reson Imaging 20: 395–402
Yuan C, Kerwin WS (2004) MRI of atherosclerosis. J Magn Reson Imaging 19: 710–719
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baer, F.M. Frühdiagnostik der funktionell relevanten koronaren Herzerkrankung. Internist 46, 389–400 (2005). https://doi.org/10.1007/s00108-005-1368-y
Issue Date:
DOI: https://doi.org/10.1007/s00108-005-1368-y